OGC
SURF

One68 Global Capital’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

One68 Global Capital’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$139K Buy
+15,071
New +$131K 0.28% 79

Other funds holding SURF

AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
AVAX
Atlas Venture Associates XI Cambridge, Massachusetts $631M AUM
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

One68 Global Capital's SURF Position: Q4 2020 in Review

One68 Global Capital opened a new position in Surface Oncology, Inc. Common Stock (SURF) in Q4 2020: 15,071 shares worth $139K. The stake represents 0.28% of the portfolio and ranks #79 among its holdings.

91 funds tracked by Wall St. Rank hold SURF as of Q4 2020.

  • One68 Global Capital held 15,071 shares of Surface Oncology, Inc. Common Stock worth $139K as of Q4 2020.
  • Surface Oncology, Inc. Common Stock was a new One68 Global Capital position in Q4 2020.
  • Surface Oncology, Inc. Common Stock made up 0.28% of One68 Global Capital's portfolio in Q4 2020, its #79 holding.
  • 91 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q4 2020.

Based on One68 Global Capital's 13F filing for Q4 2020, filed 16 Feb 2021.